Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Jun 13, 2016
Insider Transaction Report
Form 4
Cartt Stephen LaHue
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2016-06-10$2.93/sh+50,000$146,530→ 250,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.78 to $3.00, inclusive. The reporting person undertakes to provide to any stockholder of Asterias Biotherapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.